Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02485535
Title Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Chicago
Indications

bone marrow cancer

acute myeloid leukemia

Therapies

Selinexor

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field